Ameriprise’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.3M | Buy |
|
|||||
|
2025
Q2 | $12.7M | Buy |
|
|||||
|
2025
Q1 | $7.42M | Buy |
|
|||||
|
2024
Q4 | $8.07M | Buy |
|
|||||
|
2024
Q3 | $8.77M | Buy |
|
|||||
|
2024
Q2 | $8.8M | Buy |
|
|||||
|
2024
Q1 | $10.7M | Buy |
|
|||||
|
2023
Q4 | $8M | Buy |
|
|||||
|
2023
Q3 | $5.23M | Sell |
|
|||||
|
2023
Q2 | $7.26M | Buy |
|
|||||
|
2023
Q1 | $3.77M | Buy |
|
|||||
|
2022
Q4 | $2.33M | Sell |
|
|||||
|
2022
Q3 | $6.89M | Buy |
|
|||||
|
2022
Q2 | $3.59M | Buy |
|
|||||
|
2022
Q1 | $3.38M | Buy |
|
|||||
|
2021
Q4 | $3.48M | Sell |
|
|||||
|
2021
Q3 | $37.7M | Sell |
|
|||||
|
2021
Q2 | $54.5M | Sell |
|
|||||
|
2021
Q1 | $56.8M | Buy |
|
|||||
|
2020
Q4 | $68.5M | Sell |
|
|||||
|
2020
Q3 | $52.6M | Sell |
|
|||||
|
2020
Q2 | $78.4M | Buy |
|
|||||
|
2020
Q1 | $34.6M | Buy |
|
|||||
|
2019
Q4 | $28.6M | Buy |
|
|||||
|
2019
Q3 | $843K | Sell |
|
|||||
|
2019
Q2 | $971K | Sell |
|
|||||
|
2019
Q1 | $853K | Buy |
|
|||||
|
2018
Q4 | $648K | Sell |
|
|||||
|
2018
Q3 | $2.15M | Sell |
|
|||||
|
2018
Q2 | $2.99M | Buy |
|
|||||
|
2018
Q1 | $1.17M | Buy |
|